Conrad joined MVM in 2024. Prior to MVM, he worked at ClearView Healthcare Partners where he supported life science companies on strategy and commercialization across therapeutic areas, including oncology and immunology, and diligenced numerous therapeutic modalities for private equity firms. He received a B.A. summa cum lade in Biology with a minor in Financial Economics from Dartmouth College.

Latest news